<?xml version="1.0" encoding="UTF-8"?>
<p>Diabetes mellitus is a chronic metabolic disease characterized by lacking in production and or utilization of insulin. Hyperglycemia or increased blood sugar leads to serious damage to many of the body systems, especially the nerves and blood vessels.
 <sup>
  <xref ref-type="bibr" rid="ref1">1</xref>
 </sup> Type-2 diabetes mellitus (T2DM) characterized due to metabolic disorders in the endocrine system where insufficient insulin secretion and its resistance are the basic pathologic characteristics.
 <sup>
  <xref ref-type="bibr" rid="ref2">2</xref>
 </sup> Although α-amylase and α-glucosidase enzymes play a crucial role as digestive enzymes in hyperglycemia, the α-amylase enzyme is responsible in breaking down alpha bonds of alpha-linked polysaccharides, whereas α-glucosidase acknowledged to control postprandial hyperglycemia. Along with, a simultaneous therapy as antioxidants, α-amylase, and α-glucosidase inhibitors provides enough potential to present the onsets of diabetes and give a reversal therapy to a diabetic patient.
 <sup>
  <xref ref-type="bibr" rid="ref3">3</xref>
 </sup>
</p>
